Cargando…
Formononetin attenuates monocrotaline-induced pulmonary arterial hypertension via inhibiting pulmonary vascular remodeling in rats
Pulmonary arterial hypertension (PAH) is a life-threatening disease induced by the excessive proliferation and reduced apoptosis of pulmonary artery smooth muscle cells (PASMCs). Formononetin (FMN) is a natural isoflavone with numerous cardioprotective properties, which can inhibit the proliferation...
Autores principales: | Cai, Changhong, Xiang, Yijia, Wu, Yonghui, Zhu, Ning, Zhao, Huan, Xu, Jian, Lin, Wensheng, Zeng, Chunlai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6854580/ https://www.ncbi.nlm.nih.gov/pubmed/31702810 http://dx.doi.org/10.3892/mmr.2019.10781 |
Ejemplares similares
-
Inhibitory effects of formononetin on the monocrotaline-induced pulmonary arterial hypertension in rats
por: Wu, Yonghui, et al.
Publicado: (2020) -
Sodium Selenite Attenuates Balloon Injury-Induced and Monocrotaline-Induced Vascular Remodeling in Rats
por: Cai, Changhong, et al.
Publicado: (2021) -
Icariin Attenuates Monocrotaline-Induced Pulmonary Arterial Hypertension via the Inhibition of TGF-β1/Smads Pathway in Rats
por: Xiang, Yijia, et al.
Publicado: (2020) -
Naringin Ameliorates Monocrotaline-Induced Pulmonary Arterial Hypertension Through Endothelial-To-Mesenchymal Transition Inhibition
por: Wu, Yonghui, et al.
Publicado: (2021) -
Shikonin improves pulmonary vascular remodeling in monocrotaline‑induced pulmonary arterial hypertension via regulation of PKM2
por: Li, Wenfeng, et al.
Publicado: (2023)